BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 16814911)

  • 1. The health effects of chrysotile: current perspective based upon recent data.
    Bernstein DM; Hoskins JA
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):252-64. PubMed ID: 16814911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():49-73. PubMed ID: 18686078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of potency factors for asbestos-related lung cancer and mesothelioma.
    Berman DW; Crump KS
    Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure.
    Bernstein DM; Chevalier J; Smith P
    Inhal Toxicol; 2005 Aug; 17(9):427-49. PubMed ID: 16020039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
    Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
    Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
    Gamble JF; Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health risk of chrysotile revisited.
    Bernstein D; Dunnigan J; Hesterberg T; Brown R; Velasco JA; Barrera R; Hoskins J; Gibbs A
    Crit Rev Toxicol; 2013 Feb; 43(2):154-83. PubMed ID: 23346982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asbestos fiber concentrations in the lungs of brake repair workers: commercial amphiboles levels are predictive of chrysotile levels.
    Marsh GM; Youk AO; Roggli VL
    Inhal Toxicol; 2011 Oct; 23(12):681-8. PubMed ID: 21671853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Calidria chrysotile asbestos to pure tremolite: inhalation biopersistence and histopathology following short-term exposure.
    Bernstein DM; Chevalier J; Smith P
    Inhal Toxicol; 2003 Dec; 15(14):1387-419. PubMed ID: 14648356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The toxicological response of Brazilian chrysotile asbestos: a multidose subchronic 90-day inhalation toxicology study with 92-day recovery to assess cellular and pathological response.
    Bernstein DM; Rogers R; Smith P; Chevalier J
    Inhal Toxicol; 2006 May; 18(5):313-32. PubMed ID: 16513591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The health risk of chrysotile asbestos.
    Bernstein DM
    Curr Opin Pulm Med; 2014 Jul; 20(4):366-70. PubMed ID: 24811832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats.
    Hesterberg TW; Hart GA; Chevalier J; Miiller WC; Hamilton RD; Bauer J; Thevenaz P
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):68-82. PubMed ID: 9875301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.
    Hodgson JT; Darnton A
    Ann Occup Hyg; 2000 Dec; 44(8):565-601. PubMed ID: 11108782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral phases and some reexamined characteristics of the International Union Against Cancer standard asbestos samples.
    Kohyama N; Shinohara Y; Suzuki Y
    Am J Ind Med; 1996 Nov; 30(5):515-28. PubMed ID: 8909601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asbestos-related disease in the workplace and the environment: controversial issues.
    Churg A
    Monogr Pathol; 1993; (36):54-77. PubMed ID: 8107699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of mesothelioma from exposure to chrysotile asbestos.
    Yarborough CM
    Curr Opin Pulm Med; 2007 Jul; 13(4):334-8. PubMed ID: 17534182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results.
    Bernstein DM; Rogers RA; Sepulveda R; Donaldson K; Schuler D; Gaering S; Kunzendorf P; Chevalier J; Holm SE
    Inhal Toxicol; 2010 Sep; 22(11):937-62. PubMed ID: 20695727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biopersistence of brazilian chrysotile asbestos following inhalation.
    Bernstein DM; Rogers R; Smith P
    Inhal Toxicol; 2004; 16(11-12):745-61. PubMed ID: 16036745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Airborne fibre concentrations and lung burden compared to the tumour response in rats and humans exposed to asbestos.
    Rödelsperger K; Woitowitz HJ
    Ann Occup Hyg; 1995 Oct; 39(5):715-25. PubMed ID: 8526402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer.
    Goodman JE; Peterson MK; Bailey LA; Kerper LE; Dodge DG
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):8-15. PubMed ID: 24189076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.